{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=High+Activity&page=79", "query": { "intervention": "High Activity", "page": 79 }, "page_size": 10 }, "pagination": { "page": 79, "page_size": 10, "total_count": 2761, "total_pages": 277, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=High+Activity&page=80&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=High+Activity&page=78&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-11T09:35:30.686Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05148936", "title": "Communities Fighting COVID-19!", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "COVID-19 Testing Home-based (Aim 1)", "type": "OTHER" }, { "name": "COVID-19 Testing Mobile (Aim 1)", "type": "OTHER" }, { "name": "COVID-19 Testing Mobile Approach 1 (Aim 2)", "type": "OTHER" }, { "name": "COVID-19 Testing Mobile Approach 2 (Aim 2)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "San Diego State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "6 Years to 120 Years" }, "enrollment_count": 32750, "start_date": "2020-10-25", "completion_date": "2023-08-25", "has_results": false, "last_update_posted_date": "2024-06-14", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05148936" }, { "nct_id": "NCT05860257", "title": "Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety Depression", "Suicidal Ideation" ], "interventions": [ { "name": "PeerLearning.net", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Oregon", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "14 Years to 65 Years" }, "enrollment_count": 1200, "start_date": "2023-09-01", "completion_date": "2027-06-15", "has_results": false, "last_update_posted_date": "2025-10-03", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 3, "location_summary": "Tempe, Arizona • Eugene, Oregon • Madison, Wisconsin", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Eugene", "state": "Oregon" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05860257" }, { "nct_id": "NCT03346057", "title": "Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Reversal of Neuromuscular Blockade" ], "interventions": [ { "name": "Sugammadex 2 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 4 mg/kg", "type": "DRUG" }, { "name": "Sugammadex 16 mg/kg", "type": "DRUG" }, { "name": "Neostigmine + Glycopyrrolate", "type": "DRUG" }, { "name": "Rocuronium", "type": "DRUG" }, { "name": "Vecuronium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 344, "start_date": "2017-12-20", "completion_date": "2019-09-04", "has_results": true, "last_update_posted_date": "2020-10-08", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Loma Linda, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03346057" }, { "nct_id": "NCT04779307", "title": "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "Vedolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 121, "start_date": "2021-10-19", "completion_date": "2025-07-01", "has_results": true, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 11, "location_summary": "Phoenix, Arizona • San Diego, California • Atlanta, Georgia + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Park Ridge", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04779307" }, { "nct_id": "NCT06296251", "title": "Dietary Supplementation on Body Fat Composition", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dyslipidemias", "Pre-diabetes" ], "interventions": [ { "name": "Placebo treatment", "type": "OTHER" }, { "name": "Plant derived phenolics", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "OTHER", "DIETARY_SUPPLEMENT" ], "sponsor": "Brightseed", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 150, "start_date": "2024-04-18", "completion_date": "2025-02-27", "has_results": false, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 1, "location_summary": "Addison, Illinois", "locations": [ { "city": "Addison", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06296251" }, { "nct_id": "NCT07480018", "title": "Berberine Supplementation, Sprint Interval Training, and Immune Function Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Berberine", "Sprint Training", "Wellbeing", "Anaerobic Power", "Inflammation Biomarkers", "Monocyte Function" ], "interventions": [ { "name": "Berberine", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Sprint Interval Training", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "University of Northern Colorado", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 40, "start_date": "2026-01-01", "completion_date": "2026-06-01", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 1, "location_summary": "Greeley, Colorado", "locations": [ { "city": "Greeley", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07480018" }, { "nct_id": "NCT02977962", "title": "Treatment of Anxiety in Late Adolescents With Autism", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autism Spectrum Disorder" ], "interventions": [ { "name": "Cognitive-Behavior Therapy", "type": "BEHAVIORAL" }, { "name": "Treatment as Usual", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "16 Years to 21 Years" }, "enrollment_count": 44, "start_date": "2017-01", "completion_date": "2021-08", "has_results": false, "last_update_posted_date": "2020-04-24", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 1, "location_summary": "St. Petersburg, Florida", "locations": [ { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02977962" }, { "nct_id": "NCT07493096", "title": "Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neurodevelopmental Disorders", "Neurodevelopmental Disorders (NDD)", "Neurodevelopmental Disorders and Developmental Abnormalities", "Developmental Delay (Disorder)", "Cerebral Palsy (CP)", "Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment", "Cerebral Palsy Infantile", "Cerebral Palsy Spastic Hemiplegic", "Cerebral Palsy, Dyskinetic", "Autism Spectrum Disorder", "Autism Spectrum Disorder (ASD", "Hypoxic Ischemic Encephalopathy", "Hypoxic Ischemic Encephalopathy (HIE)", "Traumatic Brain Injury (TBI)", "Sensory Processing Disorder", "Chromosomal Abnormalities", "Genetic Disorders", "Down Syndrome (Trisomy 21)", "Fragile X Syndrome (FXS)", "RETT Syndrome With Proven MECP2 Mutation", "Williams Syndrome", "22q11.2 Deletion Syndrome", "Sensorimotor Integration" ], "interventions": [], "intervention_types": [], "sponsor": "Healing Hope International", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "4 Years to 12 Years" }, "enrollment_count": 100, "start_date": "2026-03-01", "completion_date": "2036-12-30", "has_results": false, "last_update_posted_date": "2026-03-25", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 1, "location_summary": "The Woodlands, Texas", "locations": [ { "city": "The Woodlands", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07493096" }, { "nct_id": "NCT07871396", "title": "Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females on Hormone Therapy", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postmenopausal Female Patients", "Vasomotor Symptoms", "Menopausal Hormone Therapy" ], "interventions": [ { "name": "Moderate Intensity Exercise (MIE)", "type": "OTHER" }, { "name": "High intensity exercise (HIE)", "type": "OTHER" }, { "name": "Control (No exercise)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "45 Years to 75 Years · Female only" }, "enrollment_count": 24, "start_date": "2026-10-15", "completion_date": "2028-01-30", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07871396" }, { "nct_id": "NCT02525861", "title": "GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alpha1-antitrypsin Deficiency" ], "interventions": [ { "name": "GLASSIA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2016-03-08", "completion_date": "2020-07-29", "has_results": true, "last_update_posted_date": "2021-10-14", "last_synced_at": "2026-11-11T09:35:30.686Z", "location_count": 17, "location_summary": "Tucson, Arizona • Los Angeles, California • Sacramento, California + 13 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02525861" } ] }